New Mexico Oncologist Pleads Guilty to Providing Misbranded Cancer Medications to Patients

Dr. Mohamed Basel Aswad of Deming, New Mexico has admitted in court that he purchased misbranded and mislabeled cancer medication from a Canadian medication supplier. On November 4, 2014 Dr. Mohamed Basel Aswad pleaded guilty in an Albuquerque courtroom to misdemeanor charges that he introduced misbranded drugs into interstate commerce, the Department of Justice (DOJ)…

[...]